For example, ATR inhibition has been shown to sensitize PARP inhibitor‐resistant BRCA1 mutant cancer cells to PARP inhibition through blocking protection of stalled replication forks (Yazinski et al., 2017). This evidence concerns the gene PARP1 and cancer.